"10.1371_journal.pone.0048304","plos one","2012-10-29T00:00:00Z","Stephen A Kaba; Margaret E McCoy; Tais A P F Doll; Clara Brando; Qin Guo; Debleena Dasgupta; Yongkun Yang; Christian Mittelholzer; Roberta Spaccapelo; Andrea Crisanti; Peter Burkhard; David E Lanar","Malaria Vaccine Branch, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America; Institute of Materials Science, University of Connecticut, Storrs, Connecticut, United States of America; M.E. MÃ¼ller Institute for Structural Biology, University of Basel, Basel, Switzerland; Department of Experimental Medicine, Microbiology Section, University of Perugia, Perugia, Italy; Imperial College London, London, United Kingdom; Department of Molecular and Cell Biology, University of Connecticut, Storrs, Connecticut, United States of America","Conceived and designed the experiments: SAK MEM PB DEL. Performed the experiments: SAK MEM TAPFD CB QG DD YY CM RS. Analyzed the data: SAK MEM CM AC PB DEL. Contributed reagents/materials/analysis tools: RS AC PB. Wrote the paper: SAK MEM DEL.","The authors have read the journals policy and have the following conflicts: PB has an interest in the company Alpha-O Peptides. Dr. Peter Burkhard holds the following EU patents: EP1594469B1 Peptidic Nanoparticles as Drug Delivery and Antigen Display Systems. EP08101221.3 Self-assembling peptide nanoparticles useful as vaccines. Dr. Burkhard and Dr. Lanar have applied for a US Patent: U.S. Application PCT/US09/49131. EFS ID: 5610500; Malaria Vaccine of Self-Assembling Polypeptide Nanoparticles. Filed 29 Jun 2009. There are no further patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2012","10","Stephen A Kaba","SAK",12,TRUE,4,9,6,3,TRUE,TRUE,FALSE,0,NA,FALSE
